文献速递消化内镜消化道肿瘤与早癌

人工智能系统EndoBRAIN提高结直肠肿瘤内镜识别准确率

Artificial Intelligence-assisted System Improves Endoscopic Identification of Colorectal Neoplasms.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-09-13

EndoBRAIN系统基于69,142张内镜细胞镜图像训练,并在100例病例的回顾性比较中,对染色内镜细胞镜图像识别肿瘤的敏感度96.9%、特异度100%、准确率98%,对窄带成像的敏感度96.9%、特异度94.3%、准确率96.0%,均显著优于受训内镜医师,多数指标与专家相当。

要点

  • EndoBRAIN对染色内镜细胞镜图像识别肿瘤的准确率达98%,显著高于内镜医师。
  • 对窄带成像,EndoBRAIN的敏感度和阴性预测值显著高于专家,其余指标与专家相当。
  • 该系统已获日本监管机构批准临床使用,可用于小息肉的内镜评估。

核心结论

  • EndoBRAIN在染色内镜细胞镜图像和窄带成像下均能准确区分肿瘤性与非肿瘤性结直肠病变,以病理为参考标准。

研究设计与样本

  • 多中心回顾性比较研究,EndoBRAIN系统先用69,142张520倍放大的内镜细胞镜图像训练,训练图像来自2017年10月至2018年3月日本5个学术中心接受内镜的结直肠息肉患者。
  • 诊断性能比较对象为30名内镜医师(20名受训医师和10名专家),评估100例病例的白光显微、亚甲蓝染色内镜细胞镜和窄带成像内镜细胞镜图像。
  • EndoBRAIN仅评估内镜细胞镜图像,不评估白光图像;主要结局为区分肿瘤与非肿瘤的准确率,以病理分析为参考标准。

主要发现

  • 分析染色内镜细胞镜图像时,EndoBRAIN识别结肠病变的敏感度96.9%(95%CI 95.8%-97.8%)、特异度100%(95%CI 99.6%-100%)、准确率98%(95%CI 97.3%-98.6%)、阳性预测值100%(95%CI 99.8%-100%)、阴性预测值94.6%(95%CI 92.7%-96.1%)。
  • 分析窄带成像时,EndoBRAIN区分肿瘤性与非肿瘤性病变的敏感度96.9%(95%CI 95.8%-97.8%)、特异度94.3%(95%CI 92.3%-95.9%)、准确率96.0%(95%CI 95.1%-96.8%)、阳性预测值96.9%(95%CI 95.8%-97.8%)、阴性预测值94.3%(95%CI 92.3%-95.9%)。
  • 染色内镜细胞镜图像分析中,EndoBRAIN的各项指标均显著高于受训医师和专家。
  • 窄带成像分析中,EndoBRAIN的各项指标均显著高于受训医师;与专家相比,敏感度和阴性预测值显著更高,其他指标相当。

关键数值与推荐

  • 染色内镜细胞镜图像:敏感度96.9%(95%CI 95.8%-97.8%),特异度100%(95%CI 99.6%-100%),准确率98%(95%CI 97.3%-98.6%),阳性预测值100%(95%CI 99.8%-100%),阴性预测值94.6%(95%CI 92.7%-96.1%)。
  • 窄带成像:敏感度96.9%(95%CI 95.8%-97.8%),特异度94.3%(95%CI 92.3%-95.9%),准确率96.0%(95%CI 95.1%-96.8%),阳性预测值96.9%(95%CI 95.8%-97.8%),阴性预测值94.3%(95%CI 92.3%-95.9%)。

临床怎么用

  • EndoBRAIN已获日本监管机构批准临床使用,可用于内镜下小息肉的评估。
  • 该系统可辅助社区非专家内镜医师提高结直肠肿瘤内镜诊断性能,减少不必要的息肉切除及相关并发症。

局限性

  • 本研究为回顾性比较分析,训练和评估图像来自特定学术中心,外部泛化性需进一步验证。
  • EndoBRAIN仅评估内镜细胞镜图像,未评估白光图像。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Precise optical diagnosis of colorectal polyps could improve the cost-effectiveness of colonoscopy and reduce polypectomy-related complications. However, it is difficult for community-based non-experts to obtain sufficient diagnostic performance. Artificial intelligence-based systems have been developed to analyze endoscopic images; they identify neoplasms with high accuracy and low interobserver variation. We performed a multi-center study to determine the diagnostic accuracy of EndoBRAIN, an artificial intelligence-based system that analyzes cell nuclei, crypt structure, and microvessels in endoscopic images, in identification of colon neoplasms. METHODS: The EndoBRAIN system was initially trained using 69,142 endocytoscopic images, taken at 520-fold magnification, from patients with colorectal polyps who underwent endoscopy at 5 academic centers in Japan from October 2017 through March 2018. We performed a retrospective comparative analysis of the diagnostic performance of EndoBRAIN vs that of 30 endoscopists (20 trainees and 10 experts); the endoscopists assessed images from 100 cases produced via white-light microscopy, endocytoscopy with methylene blue staining, and endocytoscopy with narrow-band imaging. EndoBRAIN was used to assess endocytoscopic, but not white-light, images. The primary outcome was the accuracy of EndoBrain in distinguishing neoplasms from non-neoplasms, compared with that of endoscopists, using findings from pathology analysis as the reference standard. RESULTS: In analysis of stained endocytoscopic images, EndoBRAIN identified colon lesions with 96.9% sensitivity (95% CI, 95.8%-97.8%), 100% specificity (95% CI, 99.6%-100%), 98% accuracy (95% CI, 97.3%-98.6%), a 100% positive-predictive value (95% CI, 99.8%-100%), and a 94.6% negative-predictive (95% CI, 92.7%-96.1%); these values were all significantly greater than those of the endoscopy trainees and experts. In analysis of narrow-band images, EndoBRAIN distinguished neoplastic from non-neoplastic lesions with 96.9% sensitivity (95% CI, 95.8-97.8), 94.3% specificity (95% CI, 92.3-95.9), 96.0% accuracy (95% CI, 95.1-96.8), a 96.9% positive-predictive value, (95% CI, 95.8-97.8), and a 94.3% negative-predictive value (95% CI, 92.3-95.9); these values were all significantly higher than those of the endoscopy trainees, sensitivity and negative-predictive value were significantly higher but the other values are comparable to those of the experts. CONCLUSIONS: EndoBRAIN accurately differentiated neoplastic from non-neoplastic lesions in stained endocytoscopic images and endocytoscopic narrow-band images, when pathology findings were used as the standard. This technology has been authorized for clinical use by the Japanese regulatory agency and should be used in endoscopic evaluation of small polyps more widespread clinical settings. UMIN clinical trial no: UMIN000028843.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Kudo SE, Misawa M, Mori Y, et al. Artificial Intelligence-assisted System Improves Endoscopic Identification of Colorectal Neoplasms. Clin Gastroenterol Hepatol. 2019. PMID: 31525512. doi:10.1016/j.cgh.2019.09.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。